In vitro activity of AZD2563, a novel oxazolidinone, against European Gram-positive cocci

被引：16
|
作者：
Fluit, AC [1 ]
Schmitz, FJ [1 ]
Verhoef, J [1 ]
Milatovic, D [1 ]
机构：
[1] UMCU, Eijkman Winkler Ctr, NL-3508 GA Utrecht, Netherlands
来源：
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2002年 / 50卷 / 02期
关键词：
D O I：
10.1093/jac/dkf109
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
AZD2563 is a new oxazolidinone that has targeted activity against Gram-positive bacteria. The in vitro activity of AZD2563 and nine comparators against 1543 European enterococcal, staphylococcal and streptococcal isolates was determined. The compound is a potent oxazolidinone, with no isolate tested displaying an MIC > 4 mg/L and 94.4% having an MIC less than or equal to2 mg/L. Compared with linezolid, the distribution of MICs for all species of bacteria tested, with the exception of Enterococcus faecium, was shifted by one or two dilution steps to lower values for AZD2563. Thus, this oxazolidinone is a promising new antibiotic for the treatment of infections with Gram-positive cocci.
引用
收藏
页码：271 / 276
页数：6
相关论文
共 50 条
  • [1] In vitro activity of a novel oxazolidinone, AZD2563, against randomly selected and multiresistant Gram-positive cocci
    Johnson, AP
    Warner, M
    Livermore, DM
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 50 (01) : 89 - 93
  • [2] In vitro evaluation of AZD2563, a new oxazolidinone, tested against unusual Gram-positive species
    Jones, RN
    Biedenbach, DJ
    Anderegg, TR
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2002, 42 (02) : 119 - 122
  • [3] In vitro activity of the new oxazolidinone AZD2563 against enterococci
    Eliopoulos, GM
    Wennersten, CB
    Moellering, RC
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (10) : 3273 - 3275
  • [4] In vitro evaluation of AZD2563, a novel oxazolidinone, against 603 recent staphylococcal isolates
    Anderegg, TR
    Biedenbach, DJ
    Jones, RN
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (08) : 2662 - 2664
  • [5] Activity of AZD2563, a novel oxazolidinone, against Staphylococcus aureus strains with reduced susceptibility to vancomycin or linezolid
    Howe, RA
    Wootton, M
    Noel, AR
    Bowker, KE
    Walsh, TR
    MacGowan, AP
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (11) : 3651 - 3652
  • [6] In vitro activity of teicoplanin against gram-positive cocci
    Allouch, P
    Pina, P
    Chaplain, C
    Delarbre, JM
    Geffroy, F
    Grasmick, CP
    Marcolin, M
    Morel, A
    Pangon, B
    Rio, Y
    Sédaillan, A
    PATHOLOGIE BIOLOGIE, 2000, 48 (08): : 792 - 795
  • [7] In vitro evaluation of AZD2563, a new oxazolidinone, tested against β-haemolytic and viridans group streptococci
    Anderegg, TR
    Biedenbach, DJ
    Jones, RN
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 49 (06) : 1019 - 1021
  • [8] Comparative in vitro activity of ceftobiprole against Gram-positive cocci
    Betriu, Carmen
    Culebras, Esther
    Gomez, Maria
    Lopez-Fabal, Fatima
    Rodriguez-Avial, Iciar
    Picazo, Juan J.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2010, 36 (02) : 111 - 113
  • [9] IN-VITRO ACTIVITY OF TROSPECTROMYCIN AGAINST GRAM-POSITIVE COCCI
    BEAM, TR
    GORZYNSKI, EA
    ROTSTEIN, C
    AMSTERDAM, D
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1995, 36 (05) : 874 - 878
  • [10] Antipneumococcal activity of AZD2563, a new oxazolidinone, compared with nine other agents
    Peric, M
    Lin, G
    Clark, CL
    Jacobs, MR
    Appelbaum, PC
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 50 (01) : 95 - 100
12345